Legal & General Group
PFE icon

Legal & General Group’s Pfizer PFE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$932M Buy
38,444,771
+1,384,227
+4% +$33.6M 0.23% 74
2025
Q1
$939M Buy
37,060,544
+153,979
+0.4% +$3.9M 0.26% 72
2024
Q4
$979M Sell
36,906,565
-955,377
-3% -$25.3M 0.26% 62
2024
Q3
$1.1B Buy
37,861,942
+702,070
+2% +$20.3M 0.29% 53
2024
Q2
$1.04B Sell
37,159,872
-3,859,034
-9% -$108M 0.29% 54
2024
Q1
$1.14B Sell
41,018,906
-513,451
-1% -$14.2M 0.33% 50
2023
Q4
$1.2B Sell
41,532,357
-979,118
-2% -$28.2M 0.37% 41
2023
Q3
$1.41B Sell
42,511,475
-1,329,245
-3% -$44.1M 0.49% 30
2023
Q2
$1.61B Buy
43,840,720
+2,093,282
+5% +$76.8M 0.52% 27
2023
Q1
$1.7B Buy
41,747,438
+614,632
+1% +$25.1M 0.61% 24
2022
Q4
$2.11B Sell
41,132,806
-681,703
-2% -$34.9M 0.81% 18
2022
Q3
$1.83B Sell
41,814,509
-977,163
-2% -$42.8M 0.71% 19
2022
Q2
$2.24B Buy
42,791,672
+1,336,403
+3% +$70.1M 0.79% 14
2022
Q1
$2.15B Buy
41,455,269
+2,866,750
+7% +$148M 0.65% 17
2021
Q4
$2.28B Sell
38,588,519
-291,953
-0.8% -$17.2M 0.69% 16
2021
Q3
$1.67B Buy
38,880,472
+1,486,959
+4% +$64M 0.54% 23
2021
Q2
$1.46B Buy
37,393,513
+1,434,331
+4% +$56.2M 0.49% 28
2021
Q1
$1.3B Sell
35,959,182
-539,252
-1% -$19.5M 0.49% 32
2020
Q4
$1.34B Buy
36,498,434
+46,209
+0.1% +$1.7M 0.53% 29
2020
Q3
$1.34B Sell
36,452,225
-529,996
-1% -$19.5M 0.6% 24
2020
Q2
$1.21B Buy
36,982,221
+280,454
+0.8% +$9.17M 0.58% 26
2020
Q1
$1.2B Buy
36,701,767
+882,155
+2% +$28.8M 0.7% 20
2019
Q4
$1.4B Buy
35,819,612
+879,344
+3% +$34.5M 0.67% 24
2019
Q3
$1.26B Buy
34,940,268
+580,026
+2% +$20.8M 0.66% 27
2019
Q2
$1.49B Sell
34,360,242
-414,991
-1% -$18M 0.8% 18
2019
Q1
$1.48B Buy
34,775,233
+5,309,193
+18% +$225M 0.84% 17
2018
Q4
$1.29B Buy
29,466,040
+1,792,438
+6% +$78.2M 1% 12
2018
Q3
$1.22B Buy
27,673,602
+309,817
+1% +$13.7M 0.87% 12
2018
Q2
$993M Sell
27,363,785
-1,830,752
-6% -$66.4M 0.77% 20
2018
Q1
$1.04B Sell
29,194,537
-2,025,779
-6% -$71.9M 0.79% 18
2017
Q4
$1.13B Sell
31,220,316
-622,176
-2% -$22.5M 0.82% 18
2017
Q3
$1.14B Buy
31,842,492
+379,209
+1% +$13.5M 0.85% 17
2017
Q2
$1.06B Buy
31,463,283
+292,839
+0.9% +$9.84M 0.85% 18
2017
Q1
$1.07B Buy
31,170,444
+1,168,041
+4% +$40M 0.9% 17
2016
Q4
$974M Buy
30,002,403
+227,484
+0.8% +$7.39M 0.91% 17
2016
Q3
$1.01B Buy
29,774,919
+73,538
+0.2% +$2.49M 1.02% 15
2016
Q2
$1.05B Buy
29,701,381
+315,586
+1% +$11.1M 1.1% 14
2016
Q1
$871M Buy
29,385,795
+488,194
+2% +$14.5M 0.96% 17
2015
Q4
$933M Buy
28,897,601
+58,844
+0.2% +$1.9M 1.05% 15
2015
Q3
$906M Buy
28,838,757
+735,524
+3% +$23.1M 1.1% 10
2015
Q2
$942M Buy
28,103,233
+43,597
+0.2% +$1.46M 1.11% 10
2015
Q1
$976M Sell
28,059,636
-565,706
-2% -$19.7M 1.17% 8
2014
Q4
$892M Sell
28,625,342
-739,457
-3% -$23M 1.05% 13
2014
Q3
$868M Sell
29,364,799
-1,933,468
-6% -$57.2M 1.04% 13
2014
Q2
$929M Buy
31,298,267
+235,891
+0.8% +$7M 1.08% 13
2014
Q1
$998M Sell
31,062,376
-957,314
-3% -$30.7M 1.21% 11
2013
Q4
$981M Sell
32,019,690
-331,568
-1% -$10.2M 1.19% 11
2013
Q3
$929M Sell
32,351,258
-1,904,721
-6% -$54.7M 1.22% 11
2013
Q2
$960M Buy
+34,255,979
New +$960M 1.33% 10